Defective PTPN2-mediated inflammasome control had profound effects in the setting of intestinal inflammation, where loss of PTPN2 in myeloid cells resulted in highly elevated IL-1β levels that promoted the perpetuation of inflammatory reactions, resulting in increased IL-1β-dependent intestinal inflammation [114]. The gene discussed is PTPN2; the disease is inflammation.